Philips Debuts Fully Integrated Suite of Enhanced Patient Monitoring Solutions in U.S. Market

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced the launch of its next-generation Patient Monitoring solution in the U.S. The enterprise-wide system consists of bedside, transport, mobile and central station monitoring technology backed by a new approach to consulting, training, service and customer support, including a full range of product support and expert services. The latest offering features the IntelliVue X3, a transport monitor with intuitive smart-phone-style operation released in 2017. By harmonizing monitoring system updates and improved service agreements, the solution is designed to help clinicians improve patient care, drive clinical performance and assist health systems in lowering costs.

When patients are admitted to the hospital, they are frequently transferred between departments, which can make it difficult for healthcare professionals to obtain complete data from monitoring systems that operate independently of one another. Incomplete data not only limits clinicians’ view into the patient’s condition, but can put a patient’s safety at risk. In a recent Philips-sponsored study, results revealed patient safety is still a top concern for physician and nurse leaders in the U.S. The results showed data is playing an increasingly important role in patient safety, with 74 percent of physician and nurse leaders saying they believe lack of patient data during in-hospital transport is a risk to patients.

"The healthcare industry is making strides to address clinician pain points, but issues such as lack of complete patient data and exhaustive alarm fatigue still remain," said Felix Baader, Business Leader, Monitoring & Analytics at Philips. "While challenges persist, there is an opportunity to improve and address the barriers that clinicians are currently facing with technology. We are aiming to provide clinicians with smarter alarms and seamless solutions to lower the chances of preventable adverse events, while helping them to improve patient care."

The IntelliVue X3 is a highly portable, dual-purpose monitor with intuitive smart-phone-style operation. With this monitor, there is no need for caregivers to change patient cables during transport or at bedside, allowing them to spend less time dealing with equipment and more time caring for the patient. With alarm fatigue a top concern for healthcare professionals, the Patient Monitoring solution also includes IntelliVue bedside monitors with Alarm Advisor, a tool that tracks how clinicians respond to alarms and alerts them when set thresholds may be too sensitive.

As a comprehensive system, the Patient Monitoring solution captures a steady stream of detailed patient data from monitors and medical devices, and feeds it securely to the hospital's EMR for virtually gap-free patient records from admission to discharge, even during transport. The integrated solution fits securely into health systems' existing IT environment, delivering vital signs, waveforms and alarms directly to caregivers. By incorporating these clinical decision support tools and advanced algorithms, caregivers have better visibility into a patient's changing condition. All Philips bedside, transport, and mobile monitors share the same look, feel, and interface for consistency and to reduce complexity, accelerate care, making it easier for clinicians to provide the best quality care throughout patients' transports around the hospital.

The Patient Monitoring solution is available in the U.S. The newest offering in the solution, IntelliVue X3, has recently received 510(k) clearance in the U.S.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 73,000 employees with sales and services in more than 100 countries.

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...

New AI Tool Makes Medical Imaging Proces…

When doctors analyze a medical scan of an organ or area in the body, each part of the image has to be assigned an anatomical label. If the brain is...